The Wild and Woolly World of Anti-VEGF in 2023

A once-simple treatment protocol has gotten more sophisticated—and complicated—by novel drug compounds, varied dosing regimens and sustained-release delivery methods. Here’s the current state of affairs.

Corneal Sensitivity Impaired in PDR Eyes, Not Reversed With Anti-VEGF Therapy

Assessment should be a standard screening test, as it may identify patients at risk for additional complications, such as diabetic keratopathy.

Diabetes Sufferers Without Ocular Involvement Lag Behind in Routine Eyecare

While those with vision difficulty are better connected to eye care, significant disparities in this field persist for marginalized groups in the US.

Psoriasis a Risk Factor for RVO in Diabetes Patients

The disease’s systemic inflammatory state and elevated risk of vascular complications may have ocular consequences, study shows.

Risk Factors For DR Progression Found in Pregnant Women

Type of diabetes, HbA1c level at onset of pregnancy, gestational age, hypertension status and intravitreal injection history during pregnancy all showed to be risk factors.

DR Risk Reduction Reflected in New Public Health Education Measurement

The American Heart Association’s updated cardiovascular assessment tool known as “Life’s Essential 8” shows promise for improving preventative strategies for diabetes and, with it, diabetic eye disease.

Curtail Anti-VEGF in DME Patients with Subpar Response After Six Months

A new study also found better baseline VA predicts favorable results, though patients with worse initial acuity did show greater gains overall.

White Blood Cells May Be Useful DME Biomarkers

Inflammatory indexes obtained via CBC could be an inexpensive way to guide treatment.

Diabetic Neovascularization and Capillary Nonperfusion Follow Asymmetric Pattern

Study using ultra-widefield angiography finds the former predominates superotemporally while the latter are concentrated in the superonasal quadrant.

Depression Somewhat Prevalent in Moderate to Severe NPDR Patients

Further education about the disease and more screening may reverse the initial increased rate of depression.

Upcoming Events

October 3, 2023

Addressing a Major Gap in the Treatment of Dry Eye Disease
Location: Virtual
Presenters: Damon Dierker, OD, and Jennifer Loh, MD
Webinar: 8:00pm ET

Sponsored by Bausch + Lomb

Register here

October 5, 2023

Addressing a Major Gap in the Treatment of Dry Eye Disease
Location: Virtual
Presenters: Mile Brujic, OD, and Sheri Rowen, MD
Webinar: 7:00pm ET

Sponsored by Bausch + Lomb

Register here

October 11, 2023

Showcasing Inflammation and IOP Control
Location: Dickie Brennan's Palace Café
Presenters: Nora Cothran, OD, and Michael Chaglasian, OD
Presentation: 7:00pm CT

Sponsored by Bausch + Lomb

Register here